TRXC Stock Price: Transenterix Inc takes investors for a ride after obtaining European approvals


  • NYSEAMERICAN:TRXC finished the day in the red after rising nearly 30% at one point.
  • Transenterix received European approval for its Intelligent Surgical Unit.
  • Investors are hoping Transenterix can get a share of the nearly 6 million annual laparoscopic surgeries in the U.S. and Europe.

NYSEAMERICAN:TRXC had another rollercoaster trading session as shares surged by nearly 30% to start the day but eventually hit the red by the closing bell. This is not uncommon to see, especially with small-cap healthcare stocks which are known to be extremely volatile when good or bad news hits. Taking a look at Transenterix’s daily trading volume shows that nearly 97 million shares changed hands today, which is about six times the average daily trading volume of 16 million shares. The stock did briefly hit a new 52-week high of $4.44, before setting back down to $3.47 at the end of trading hours. 

The catalyst was European approval for Transenterix’s Intelligent Surgical Unit or ISU, which provides improved machine-vision functionality for its Senhance system which specializes in laparoscopic surgeries. Any improvement to robotic vision can only be seen as a positive when it comes to performing surgeries, so it stands to reason as to why investors have shown such excitement as of late. There are an estimated 6 million laparoscopic procedures that take place every year in both the United States and Europe, so the market for the Senhance system seems ripe for the picking.

TRXC stock forecast

TRXC stock price chart

The sudden swing in TRXC looks to be investors skimming some profits from the recent bull run as the stock begins to consolidate some of its momentum. What does this mean for the future? It is difficult to say as a fuller buy-in for robotic surgeries is still needed even if the equipment has received approvals but if industry-leader Intuitive Surgical (NASDAQ:ISRG) is any indication of how well robotics companies can do, TRXC may be in for an extended period of gains. 

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

EUR/USD holds above 1.0650 after US data

EUR/USD holds above 1.0650 after US data

EUR/USD retreats from session highs but manages to hold above 1.0650 in the early American session. Upbeat macroeconomic data releases from the US helps the US Dollar find a foothold and limits the pair's upside.

EUR/USD News

GBP/USD retreats toward 1.2450 on modest USD rebound

GBP/USD retreats toward 1.2450 on modest USD rebound

GBP/USD edges lower in the second half of the day and trades at around 1.2450. Better-than-expected Jobless Claims and Philadelphia Fed Manufacturing Index data from the US provides a support to the USD and forces the pair to stay on the back foot.

GBP/USD News

Gold clings to strong daily gains above $2,380

Gold clings to strong daily gains above $2,380

Gold trades in positive territory above $2,380 on Thursday. Although the benchmark 10-year US Treasury bond yield holds steady following upbeat US data, XAU/USD continues to stretch higher on growing fears over a deepening conflict in the Middle East.

Gold News

Ripple faces significant correction as former SEC litigator says lawsuit could make it to Supreme Court

Ripple faces significant correction as former SEC litigator says lawsuit could make it to Supreme Court

Ripple (XRP) price hovers below the key $0.50 level on Thursday after failing at another attempt to break and close above the resistance for the fourth day in a row. 

Read more

Have we seen the extent of the Fed rate repricing?

Have we seen the extent of the Fed rate repricing?

Markets have been mostly consolidating recent moves into Thursday. We’ve seen some profit taking on Dollar longs and renewed demand for US equities into the dip. Whether or not this holds up is a completely different story.

Read more

Forex MAJORS

Cryptocurrencies

Signatures